• 1
    Tabar L, Dean P. Teaching atlas of mammography. New York: Thieme, 1983.
  • 2
    American College of Radiology. Breast imaging reporting and data system (BI-RADS®). Reston, VA: American College of Radiology, 1995.
  • 3
    Parker S, Lovin J, Jube W, et al. Stereotactic breast biopsy with a biopsy gun. Radiology. 1990; 176: 741747.
  • 4
    Beck RM, Gotz L, Heywang-Kobrunner SH. Stereotaxic vacuum core breast biopsy—experience of 560 patients. Swiss Surg. 2000; 6: 108110.
  • 5
    Heywang-Kobrunner SH, Schaumloffel U, Viehweg P, Hofer H, Buchmann J, Lampe D. Minimally invasive stereotaxic vacuum core breast biopsy. Eur Radiol. 1998; 8: 377385.
  • 6
    Philpotts LE, Shaheen NA, Carter D, Lange RC, Lee CH. Comparison of rebiopsy rates after stereotactic core needle biopsy of the breast with 11-gauge vacuum suction probe versus 14-gauge needle and automatic gun. AJR Am J Roentgenol. 1999; 172: 683687.
  • 7
    Brenner RJ, Bassett LW, Fajardo LL, et al. Stereotactic core-needle breast biopsy: a multi-institutional prospective trial. Radiology. 2001; 218: 866872.
  • 8
    Fuhrman GM, Cederbom GJ, Bolton JS, et al. Image-guided core-needle breast biopsy is an accurate technique to evaluate patients with nonpalpable imaging abnormalities. Ann Surg. 1998; 227: 932939.
  • 9
    Meyer JE, Smith DN, Lester SC, et al. Large-core needle biopsy of nonpalpable breast lesions. JAMA. 1999; 281: 16381641.
  • 10
    Stolier A, Skinner J, Levine EA. A prospective study of seeding of the skin after core biopsy of the breast. Am J Surg. 2000; 180: 104107.
  • 11
    Lai JT, Burrowes P, MacGregor JH. Vacuum-assisted large-core breast biopsy: complications and their incidence. Can Assoc Radiol J. 2000; 51: 232236.
  • 12
    Diaz LK, Wiley EL, Venta LA. Are malignant cells displaced by large-gauge needle core biopsy of the breast? AJR Am J Roentgenol. 1999; 173: 13031313.
  • 13
    Harter LP, Curtis JS, Ponto G, Craig PH. Malignant seeding of the needle track during stereotaxic core needle breast biopsy. Radiology. 1992; 185: 713714.
  • 14
    Nguyen M, McCombs MM, Ghandehari S, et al. An update on core needle biopsy for radiologically detected breast lesions. Cancer. 1996; 78: 23402345.
  • 15
    Parker SH, Burbank F, Jackman RJ, et al. Percutaneous large-core breast biopsy: a multi-institutional study. Radiology. 1994; 193: 359364.
  • 16
    Clarke D, Sudhakaran N, Gateley CA. Replace fine needle aspiration cytology with automated core biopsy in the triple assessment of breast cancer. Ann R Coll Surg Engl. 2001; 83: 110112.
  • 17
    Britton PD, Flower CD, Freeman AH, et al. Changing to core biopsy in an NHS breast screening unit. Clin Radiol. 1997; 52: 764767.
  • 18
    United Kingdom National Health Service Breast Screening Programme. Guidelines for non-operative diagnostic procedures and reporting in breast cancer. Sheffield, United Kingdom: NHS Cancer Screening Programmes, 2001.
  • 19
    Holland R, Hendriks JH. Microcalcifications associated with ductal carcinoma in situ: mammographic-pathologic correlation. Semin Diagn Pathol. 1994; 11: 181192.
  • 20
    DeMay RM. The art and science of cytopathology. Chicago: American Society for Clinical Pathology Press, 1995.
  • 21
    King TA, Cederbom GJ, Champaign JL, et al. A core breast biopsy diagnosis of invasive carcinoma allows for definitive surgical treatment planning. Am J Surg. 1998; 176: 497501.
  • 22
    Renshaw AA. Predicting invasion in the excision specimen from breast core needle biopsy specimens with only ductal carcinoma in situ. Arch Pathol Lab Med. 2002; 126: 3941.
  • 23
    Zarbo RJ, Howanitz PJ, Bachner P. Interinstitutional comparison of performance in breast fine-needle aspiration cytology. A Q-probe quality indicator study. Arch Pathol Lab Med. 1991; 115: 743750.
  • 24
    Symmans WF, Weg N, Gross J, et al. A prospective comparison of stereotaxic fine-needle aspiration versus stereotaxic core needle biopsy for the diagnosis of mammographic abnormalities. Cancer. 1999; 85: 11191132.
  • 25
    Symmans WF, Cangiarella JF, Gottlieb S, Newstead GM, Waisman J. What is the role of cytopathologists in stereotaxic needle biopsy of nonpalpable mammographic abnormalities? Diagn Cytopathol. 2001; 24: 260270.
  • 26
    Westenend PJ, Sever AR, Beekman-De Volder HJ, Liem SJ. A comparison of aspiration cytology and core needle biopsy in the evaluation of breast lesions. Cancer. 2001; 93: 146150.
  • 27
    Hatada T, Ishii H, Ichii S, Okada K, Fujiwara Y, Yamamura T. Diagnostic value of ultrasound-guided fine-needle aspiration biopsy, core-needle biopsy, and evaluation of combined use in the diagnosis of breast lesions. J Am Coll Surg. 2000; 190: 299303.
  • 28
    Jackman RJ, Nowels KW, Rodriguez-Soto J, Marzoni FA Jr., Finkelstein SI, Shepard MJ. Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: false-negative and histologic underestimation rates after long-term follow-up. Radiology. 1999; 210: 799805.
  • 29
    Lee CH, Philpotts LE, Horvath LJ, Tocino I. Follow-up of breast lesions diagnosed as benign with stereotactic core-needle biopsy: frequency of mammographic change and false-negative rate. Radiology. 1999; 212: 189194.
  • 30
    Burns RP, Brown JP, Roe SM, Sprouse LR II, Yancey AE, Witherspoon LE. Stereotactic core-needle breast biopsy by surgeons: minimum 2-year follow-up of benign lesions. Ann Surg. 2000; 232: 542548.
  • 31
    Adler DD, Light RJ, Granstrom P, Hunter TB, Hunt KR. Follow-up of benign results of stereotactic core breast biopsy. Acad Radiol. 2000; 7: 248253.
  • 32
    Ibrahim AE, Bateman AC, Theaker JM, et al. The role and histological classification of needle core biopsy in comparison with fine needle aspiration cytology in the preoperative assessment of impalpable breast lesions. J Clin Pathol. 2001; 54: 121125.